Testing effectiveness (Phase 2)UnknownNCT04221516
What this trial is testing
Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma
Who this might be right for
Nasopharyngeal CarcinomaOligometastasisRadiotherapy
Nanfang Hospital, Southern Medical University 52